Research Associate, Department of Oral Surgery and Implantology, Carolinum, Goethe University, Frankfurt, Germany.
Oral Surgeon, Department of Oral Surgery and Implantology, Carolinum, Johann Wolfgang Goethe-University Frankfurt, Frankfurt, Germany.
Implant Dent. 2019 Apr;28(2):187-209. doi: 10.1097/ID.0000000000000839.
To address the focused question: "In patients with osseointegrated implants diagnosed with periimplantitis, what are the clinical and radiographic outcomes of augmentative surgical interventions compared with nonaugmentative surgical measures"?
Literature screening was performed in MEDLINE through the PubMed database, for articles published until January 1, 2018. Human studies reporting on the clinical (ie, bleeding on probing [BOP] and probing depth [PD] changes) and/or radiographic (ie, periimplant defect reduction and/or fill) treatment outcomes after surgical augmentative periimplantitis therapy, and/or comparing augmentative and nonaugmentative surgical approaches were searched.
Thirteen comparative and 11 observational clinical studies were included. Surgical augmentative periimplantitis therapy resulted in mean BOP and PD reduction ranging from 26% to 91%, and 0.74 to 5.4 mm, respectively. The reported mean radiographic fill of intrabony defects ranged between 57% and 93.3%, and defect vertical reduction varied from 0.2 to 3.77 mm. Three randomized controlled clinical studies failed to demonstrate the superiority of augmentative therapy compared with nonaugmentative approach in terms of PD and BOP reduction.
The available evidence to support superiority of augmentative surgical techniques for periimplantitis management on the treatment outcomes over nonaugmentative methods is limited.
针对聚焦问题：“在诊断患有种植体周围炎的骨整合种植体患者中，与非增强手术措施相比，增强性手术干预的临床和影像学结果如何？”
通过 PubMed 数据库中的 MEDLINE 进行文献筛选，检索截至 2018 年 1 月 1 日发表的文章。搜索报告了手术增强性种植体周围炎治疗后临床（即探诊出血[BOP]和探诊深度[PD]变化）和/或影像学（即种植体周围缺损减少和/或填充）治疗结果的，以及比较增强性和非增强性手术方法的人类研究。
共纳入 13 项对照研究和 11 项观察性临床研究。手术增强性种植体周围炎治疗后，BOP 和 PD 的平均降幅分别为 26%至 91%和 0.74 至 5.4 毫米。报告的内骨缺损平均影像学填充范围为 57%至 93.3%，缺损垂直减少范围为 0.2 至 3.77 毫米。三项随机对照临床试验未能证明增强治疗在 PD 和 BOP 减少方面优于非增强治疗方法。
目前的证据支持增强性手术技术在种植体周围炎治疗方面优于非增强性方法，在治疗效果方面具有优势。
